Experts disagree on whether DPIs or low emissions pMDIs are the way forward for effective, environmentally friendly inhalers. Credit: Orawan Pattarawimonchai ...

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 billion by 2034. The Industry is expected to surge at a CAGR of 3.70% from ...

In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder inhalers (DPIs) for respiratory conditions that are more eco-friendly ...

Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco-friendly ...

Two formulations of ipratropium for COPD were also compared in a one-year, open-label safety and effectiveness study (NCT02194205), with comparable results. Atrovent HFA, an inhalation aerosol, was ...

Am J Health Syst Pharm. 2005;62(12):1263-1269.

M1 Parasympathetic ganglia, exocrine glands, mucous glands Cholinergic neurotransmission 0.11 14.6 M2 Postganglionic cholinergic nerves, airway (smooth muscle) Negative feedback to reduce ...